At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
June 03, 2024 07:00 ET
|
Treos Bio Corp.
Treos Bio reports promising survival results for chemo-free PolyPEPI1018 cancer vaccine combined with Roche's PD-L1 inhibitor in MSS mCRC at 2024 ASCO
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
June 02, 2024 10:00 ET
|
Precede Biosciences, Inc.
HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancersER status was accurately assessed and the level of ER pathway activation quantified in 87...
Asia-Pacific Genomic Cancer Panel and Profiling Market Research 2023-2024 & 2033: Advancements in Genomic Research and Increasing Focus on Precision Medicine Within Oncology
May 30, 2024 06:39 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Genomic Cancer Panel and Profiling Market: Focus on Application, End User, and Country - Analysis and Forecast, 2023-2033" report has been...
Global Gene Editing Tools Market Report 2024: A $3.83 Billion Market by 2034, with a CAGR of 18.84% During 2024-2034
May 27, 2024 04:13 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Gene Editing Tools Market" report has been added to ResearchAndMarkets.com's offering.The global gene editing tools market accounted for USD...
Global Personalized Medicine Market Research Report 2024-2032 Featuring Abbott Laboratories, GE Healthcare, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
May 24, 2024 07:39 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Personalized Medicine Market Report by Product, Application, End-Users, Region and Company Analysis 2024-2032" report has been added to ...
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 13, 2024 06:05 ET
|
AC Immune SA
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update Landmark deal announced with Takeda for ACI-24.060 with $100 million upfront and total potential payments for...
$2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F
May 08, 2024 07:25 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Epigenetic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Genomics Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 948 Agreements Signed Since 2016
May 07, 2024 07:14 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Genomic Collaboration and Licensing...
miRNA Sequencing and Assay Market Review 2019-2023 and Forecast 2024-2029: miRNA Technologies Spearhead Custom-Tailored Therapies for Individualized Treatment
May 02, 2024 09:12 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Global Cancer Research Technologies Analysis Report 2024-2032: Key Players Striving for Innovation and Market Dominance in Genomics Technologies, Diagnostic Tools, and Therapeutic Interventions
April 30, 2024 03:09 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Cancer Research Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...